The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.
In a new scientific statement, the American Heart Association (AHA) highlights the importance of incorporating nonbiological risk factors and social determinants of health in cardiovascular disease ...